The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Regulatory & Policy

EnteroBiotix Announces MHRA License Approval and Strengthened Senior Management Team
Pharma & Human Health

EnteroBiotix Announces MHRA License Approval and Strengthened Senior Management Team

SEP 10, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing science and regulation of live microbiome-based products
Editor's Choice

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing science and regulation of live microbiome-based products

AUG 20, 2018
Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield(TM)
Pharma & Human Health

Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield(TM)

JUL 6, 2018
MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study
Clinical & Manufacturing

MHRA and HPRA Clear 4D Pharma’s Blautix Phase II Study

JUN 14, 2018
Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health
Pharma & Human Health

Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health

MAY 25, 2018
Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer
Oncology & Cancer

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

MAY 21, 2018
FDA Clears 4D Pharma’s IND Application for Blautix
Pharma & Human Health

FDA Clears 4D Pharma’s IND Application for Blautix

MAY 9, 2018
Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals
Infectious Disease & AMR

Dutch Biotech Micreos ‘Alternative to Antibiotics’ Wins Ideas From Europe Finals

APR 26, 2018